$CRTG
CORETEC GROUP INC.

2020 Q2 Form 10-Q Financial Statement

#000143774920017943 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $212.9K $170.4K
YoY Change 24.99% -18.88%
% of Gross Profit
Research & Development $36.10K $20.06K
YoY Change 79.97% -5.31%
% of Gross Profit
Depreciation & Amortization $20.06K $20.24K
YoY Change -0.89% 1.2%
% of Gross Profit
Operating Expenses $36.10K $20.06K
YoY Change 79.97% -5.31%
Operating Profit
YoY Change
Interest Expense $56.65K $95.43K
YoY Change -40.64% -1.05%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$289.6K -$285.9K
YoY Change 1.32% 50.45%
Income Tax
% Of Pretax Income
Net Earnings -$289.6K -$285.9K
YoY Change 1.32% 50.71%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.429K -$4.123K
COMMON SHARES
Basic Shares Outstanding 202.7M 68.67M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.8K $33.84K
YoY Change 218.5% 12.8%
Cash & Equivalents $107.8K $33.84K
Short-Term Investments
Other Short-Term Assets $33.34K $36.94K
YoY Change -9.75% 269.4%
Inventory
Prepaid Expenses $33.34K $36.94K
Receivables
Other Receivables
Total Short-Term Assets $141.1K $70.78K
YoY Change 99.37% 61.09%
LONG-TERM ASSETS
Property, Plant & Equipment $504.00
YoY Change -60.0%
Goodwill $166.0K $166.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.580K $2.320K
YoY Change 54.31%
Total Long-Term Assets $1.269M $1.348M
YoY Change -5.89% -5.67%
TOTAL ASSETS
Total Short-Term Assets $141.1K $70.78K
Total Long-Term Assets $1.269M $1.348M
Total Assets $1.410M $1.419M
YoY Change -0.64% -3.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $478.2K $719.6K
YoY Change -33.55% 41.1%
Accrued Expenses $633.6K
YoY Change 66.73%
Deferred Revenue
YoY Change
Short-Term Debt $5.590K $68.12K
YoY Change -91.79% 13.53%
Long-Term Debt Due $1.992M
YoY Change 34.62%
Total Short-Term Liabilities $483.8K $3.414M
YoY Change -85.83% 39.95%
LONG-TERM LIABILITIES
Long-Term Debt $186.3K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $186.3K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $483.8K $3.414M
Total Long-Term Liabilities $186.3K $0.00
Total Liabilities $670.0K $3.414M
YoY Change -80.37% 39.95%
SHAREHOLDERS EQUITY
Retained Earnings -$6.314M -$4.224M
YoY Change 49.48% 35.32%
Common Stock $40.71K $13.98K
YoY Change 191.12% 2.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $739.8K -$1.995M
YoY Change
Total Liabilities & Shareholders Equity $1.410M $1.419M
YoY Change -0.64% -3.68%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$289.6K -$285.9K
YoY Change 1.32% 50.71%
Depreciation, Depletion And Amortization $20.06K $20.24K
YoY Change -0.89% 1.2%
Cash From Operating Activities -$295.5K -$112.9K
YoY Change 161.69% -5.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 322.7K 146.7K
YoY Change 120.03% 1366.7%
NET CHANGE
Cash From Operating Activities -295.5K -112.9K
Cash From Investing Activities
Cash From Financing Activities 322.7K 146.7K
Net Change In Cash 27.27K 33.77K
YoY Change -19.25% -130.7%
FREE CASH FLOW
Cash From Operating Activities -$295.5K -$112.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1268715
CY2019Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1308830
CY2019 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y131D
crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y215D
crtg Class Of Warrant Or Right Granted Contractual Term
ClassOfWarrantOrRightGrantedContractualTerm
P4Y262D
CY2020Q2 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.052
crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
870000
crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
29691
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
703249
crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
245000
crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
502142
crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exchanged
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExchanged
1500000
CY2020Q2 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
900000
CY2019Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
7862
CY2019Q2 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
11192
CY2020Q2 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
19054
crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
300000
crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
CY2020Q2 crtg Working Capital Deficit
WorkingCapitalDeficit
342655
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
478183
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
615815
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7013160
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6135885
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
310303
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
191839
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53447
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23692
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
241776
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
45134
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40115
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40115
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
49122797
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
224616281
CY2020Q2 us-gaap Assets
Assets
1409834
CY2019Q4 us-gaap Assets
Assets
1455926
CY2020Q2 us-gaap Assets Current
AssetsCurrent
141119
CY2019Q4 us-gaap Assets Current
AssetsCurrent
146970
CY2020Q2 us-gaap Cash
Cash
107777
CY2019Q4 us-gaap Cash
Cash
58149
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58149
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4001
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107777
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33840
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49628
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29839
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
570000
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1440000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
203550642
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
193521506
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
203550642
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193521506
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
40710
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
38704
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
289632
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
285849
us-gaap Costs And Expenses
CostsAndExpenses
819939
us-gaap Costs And Expenses
CostsAndExpenses
584173
CY2020Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3575
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3575
us-gaap Depreciation
Depreciation
126
us-gaap Depreciation
Depreciation
378
us-gaap Interest Paid Net
InterestPaidNet
4423
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7560
CY2020Q2 us-gaap Liabilities
Liabilities
670027
CY2019Q4 us-gaap Liabilities
Liabilities
775461
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1409834
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1455926
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1099140
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1139255
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-137632
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
280048
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-55479
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-294
CY2020Q2 us-gaap Interest Expense
InterestExpense
56645
CY2019Q2 us-gaap Interest Expense
InterestExpense
95433
us-gaap Interest Expense
InterestExpense
277084
us-gaap Interest Expense
InterestExpense
188802
us-gaap Interest Paid Net
InterestPaidNet
36280
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.004
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.004
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.008
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
212930
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
170359
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
502740
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
355256
CY2020Q2 us-gaap Goodwill
Goodwill
166000
CY2019Q4 us-gaap Goodwill
Goodwill
166000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
483774
us-gaap Operating Lease Expense
OperatingLeaseExpense
11880
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
654953
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40115
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6314132
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5494193
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33342
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
88821
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
669703
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218352
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-620075
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-188513
us-gaap Net Income Loss
NetIncomeLoss
6314132
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-289632
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-285849
us-gaap Net Income Loss
NetIncomeLoss
-819939
us-gaap Net Income Loss
NetIncomeLoss
-584173
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-530307
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-298323
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
5591
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
39138
CY2020Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
186253
CY2019Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
120508
CY2020Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
186253
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
120508
us-gaap Operating Lease Expense
OperatingLeaseExpense
17982
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
33546
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
26648
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20057
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20057
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40115
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
20212174
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
20212174
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P4Y51D
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
29691
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
739807
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813908
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1459299
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-1749760
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-1994727
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</div></div></div></div></div>
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
202710642
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69334436
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
198166791
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68980523

Files In Submission

Name View Source Status
0001437749-20-017943-index-headers.html Edgar Link pending
0001437749-20-017943-index.html Edgar Link pending
0001437749-20-017943.txt Edgar Link pending
0001437749-20-017943-xbrl.zip Edgar Link pending
crtg-20200630.xml Edgar Link completed
crtg-20200630.xsd Edgar Link pending
crtg-20200630_cal.xml Edgar Link unprocessable
crtg-20200630_def.xml Edgar Link unprocessable
crtg-20200630_lab.xml Edgar Link unprocessable
crtg-20200630_pre.xml Edgar Link unprocessable
crtg20200630_10q.htm Edgar Link pending
ex_199350.htm Edgar Link pending
ex_199354.htm Edgar Link pending
ex_199355.htm Edgar Link pending
ex_199356.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending